James R. Tobin
At a glance: James R. Tobin is Director at TransMedics Group (TMDX). Their latest SEC Form 4, filed Nov 12, 2026, reported a sale of $6K. On file: 0 purchase lines ($0) and 5 sale lines ($5.8M).
Disclosed holdings: about $267K of TMDX stock: 2,922 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 13, 2026 close of $91.38. This counts only TMDX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Globus Medical Inc (GMED); Director at TransMedics Group, Inc. (TMDX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | TMDXTransMedics Group, Inc. | Sell | 596,922 held (−1%) | $93.96 | $6K | -2.7% |
| Nov 12SEC | TMDXTransMedics Group, Inc. | Sell | 4,0002,922 held (−58%) | $94.98 | $380K | -3.8% |
| Nov 12SEC | GMEDGlobus Medical Inc | Sell | 37,6624,004 held (−90%) | $75.10 | $2.8M | -3.9% |
| Nov 12SEC | GMEDGlobus Medical Inc | Sell | 4,004 | $75.68 | $303K | -4.7% |
| Sep 16SEC | GMEDGlobus Medical Inc | Sell | 30,000 | $74.58 | $2.2M | -3.3% |
- Sell
Director James R Tobin sold $380K of TMDX at $94.98 — cuts the stake by 58%.
- Sell
Director James R Tobin sold $2.8M of GMED at $75.10 — cuts the stake by 90%.
Follow James R. Tobin
Get one email when James R. Tobin files a new purchase or sale. Free.
At most one email a day about James R. Tobin, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.